Michael (Mike) Kucharczyk

Clinical sites

Breast, gastrointestinal, and genitourinary malignancies

Education

• Co-op HBSc (Biochemistry) – McMaster University
• MB BCh BAO (Medicine) – University College Cork
• MPH (Epidemiology) – Harvard T.H. Chan School of Public Health 
• FRCPC DABR (Radiation Oncology) – McMaster University
• Fellowship (Thoracic Brachytherapy) – McMaster University
• Fellowship (Genitourinary) – McGill University

Research interests

• Prostate cancer
• Oligometastatic disease – Metastasis-directed therapy; Patient selection
• Novel therapies
• Clinical Trials
• Radiomics – Biomarkers; Program Development
• Treatment delivery – Image guidance; Spacers

Academic interests

• Brachytherapy
• Breast & Gastrointestinal malignancies
• Immunotherapy
• Radiation Sensitisation
• Stereotactic Radiotherapy

Recent publications

• Kucharczyk MJ, Bang A, Tjong MC, Papatheodoru S, and Fabregas JC. (2022) Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis. Oncotarget, 13: 1109-19.
• Chaddad, A*, Kucharczyk, M.J*, Cheddad, A, Clarke, S.E, Hassan, L, Ding, S, Rathore, S, Zhang, M, Katib, Y, Bahoric, B, et al. Magnetic Resonance Imaging Based Radiomic Models of Prostate Cancer: A Narrative Review. Cancers  2021, 13, 552. *equal contribution to the work
• Chaddad A, Kucharczyk MJ, Katib Y, Rathore S, Sargos P, and Niazi T. (2020) Deep radiomic analysis to predict the Gleason score in prostate cancer. IEEE Access. Vol 8.     
• Kucharczyk MJ, So J, Gravis G, Sweeney C, Saad F, and Niazi T. (2020) A combined biological and clinical rationale for implementing metastasis directed therapy in the management of oligometastatic prostate cancer: a synthesis of the evidence. Radiotherapy and Oncology. Vol 152: 80-8.
  
• Kucharczyk MJ,  Tsui J, Khosrow-Khavar F, Bahoric B, Souhami L, Anidjar M, Probst S, Chaddad A, Sargos P and Niazi T. Combined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study. Frontiers in Oncology Vol 10, March 2020. 
• Ghashghaei M, Kucharczyk MJ, Elakshar S, Muanza T*, and Niazi T*. Intensifying radiotherapy with novel androgen receptor inhibitors: a review of the current upcoming clinical evidence. Current Oncology
• Chaddad A, Kucharczyk MJ, Daniel P, Sabri S, Niazi T, and Abdulkarim B. (2019) Radiomics in glioblastoma: current status and challenges facing clinical implementation. Frontiers in Oncology. Vol 9 (374).

Other interests  

• Resident Education & Mentorship
• Ultimate Frisbee
• Travel